Quarterly report pursuant to Section 13 or 15(d)

Income Taxes (Details Narrative)

v3.21.1
Income Taxes (Details Narrative) - USD ($)
3 Months Ended
Mar. 31, 2021
Mar. 31, 2020
Mar. 19, 2018
Income tax expense $ (89,248) $ (128,129)  
CoNCERT Pharmaceuticals, Inc [Member] | License Rights [Member]      
Deferred tax liability     $ 3,037,147
Intangible assets, financial reporting basis     11,038,929
Intangible assets, tax basis     $ 1,782